Neurochromatic prescription determination

Abstract

A method for determining a lens prescription for the eye. The method includes selecting a first ultraviolet (UV) trial lens and determining whether the first UV trial lens results in improvement in visual function. The first UV trial lens may be selected for the lens prescription when the first UV trial lens results in improvement in visual function. The method includes selecting a first color group comprising a first color trial lens and a second color trial lens and determining whether the first color trial lens or the second color trial lens results in greater improvement in visual function. The second color trial lens may be selected for the prescription when the second color trial lens results in greater improvement in visual function as compared to the first color trial lens. The method may include reevaluating the first UV trial lens for improvement in visual function when not previously selected.

Description

RELATED U.S. APPLICATIONS[0001]This application claims the benefit of and priority to the copending provisional patent application Ser. No. 61 / 470,417, Attorney Docket Number NCVS-0001.A, entitled “SYSTEMS AND METHODS FOR CHROMATIC VISION ENHANCEMENT,” with filing date Mar. 31, 2011, and hereby incorporated by reference in its entirety.[0002]This application is related to copending non-provisional patent application Ser. No. 13 / 368,149, Attorney Docket Number NCVS-0001.US1, entitled “NEUROCHROMATIC PRESCRIPTION DETERMINATION,” with filing date 2 / 7 / 12, and hereby incorporated by reference in its entirety.[0003]This application is related to copending non-provisional patent application Ser. No. ______, Attorney Docket Number NCVS-0001.US2, entitled “NEUROCHROMATIC TRIAL LENS KIT,” with filing date ______, and hereby incorporated by reference in its entirety.[0004]This application is related to copending non-provisional patent application Ser. No. ______, Attorney Docket Number NCVS-00...

AI Technical Summary

Benefits of technology

[0009]Embodiments of the present invention medically and therapeutically treat or enhance the performance of the human visual experience by physician prescribed neurochromatic lenses. Embodiments of the present invention further provide effective treatment for the enhancement of vision and therapeutic treatment for a variety of neurovisual processing symptoms, anomalies, conditions, and syndromes.

[0010]Embodiments of the present invention are operable to improve a variety of various visual performance and visual function characteristics including improved visual acuity (e.g., more clear and enhanced visual perception of distant objects), improved visual field, enhanced visual saccade (e.g., eye movement across a page), increased contrast sensitivity, and increased recognition of color hues. Embodiments of the present invention are further operable to improve visual performance and visual function characteristics including increased eye coordination, increased pupil stabilization (e.g., stabilization of pupil shape to round), improved visual invoked response time (e.g., vision to action time), and improved blood flow in the brain which results in enhancement to cognitive response to visual cues. Embodiments of the present invention may make use of Neurochromatic© lens or trial lens available from NeuChroma Vision, Incorporated of Redding, Calif.

Problems solved by technology

This reliance on the visual system as the primary sense for interacting with the world makes the human eye incredibly important and thereby meaning any deficiency in visual performance can have a large negative impact.

The eye and the visual processing system are quite complex and as such can be negatively impacted by a variety of conditions, syndromes, and complications.

Such problems can result in photophobia, reduced field of vision, clarity of vision, and other visual compromises.

While ophthalmic prescriptions are somewhat effective in reducing the negative effects of near-sightedness and far-sightedness, ophthalmic prescriptions and lenses are not able to solve or reduce a variety of conditions, syndromes, and complications.

For example, ophthalmic lenses have limited effect on photophobia or reduced field of vision.

Regular eye glasses mostly correct for image clarity and focus but do little to correct for other visual performance and acuity issues.

Images